Steven Scheinfeld is Global Chair of our Corporate Department and advises clients in various industries in connection with public and private securities offerings, mergers and acquisitions, corporate governance matters, financings and complex strategic partnerships.
Steve’s clients include Aerie Pharmaceuticals, Capital One, CVS Health, Fortress Infrastructure, L&M Development Partners, SL Green Realty Corp., Terex Corporation and Tradeweb Markets.
Steve is active in the boardroom community and was named a NACD Corporate Governance Fellow and recognized as a leading advisor in their “Directorship 100.” He is consistently recognized by Legal 500 in M&A: Mega-Deals and has been recognized in Capital Markets: Equity Offerings and Real Estate: Private Equity and Corporate.
M&A/PE Briefing |Important Lessons from the Court of Chancery Regarding PE Sponsors, Portco Operating Agreements, Failed Projections, and More—P3 Health Group⟶
Client memorandum |Court of Chancery Addresses Board Responsibility Under Caremark for Cybersecurity Risk—SolarWinds⟶
Client memorandum |Second Circuit Makes New Law by Establishing a Bright-Line Test for Standing to Bring Rule 10b-5 Claims Challenging a Target’s False or Misleading Pre-Merger Disclosure—Menora v. Frutarom⟶
M&A/PE Briefing |Drafting Lessons from the Court of Chancery—the Meaning of “Void,” “Subject to,” and “And”⟶
Alerts and newsletters |M&A/PE Quarterly, Fall 2022⟶
Alerts and newsletters |Fried Frank M&A/PE Quarterly Newsletter, Summer 2022⟶
M&A/PE Briefing |Court of Chancery Accepts, “With Trepidation,” at Motion to Dismiss Stage, a “Novel Theory” of Liability for Directors—Garfield⟶
Alerts and newsletters |Fried Frank M&A/PE Quarterly Newsletter, Spring 2022⟶
Client memorandum |Far-Reaching Rules Proposed by SEC Would Transform SPAC Process to Make It More Burdensome than a Traditional IPO⟶